Nestle and Danone face renewed scrutiny as reports and a French parliamentary review examine infant formula recalls

Tuesday, May 19, 2026Science & ClimateWell-covered4 frames

Nestle and Danone are under renewed scrutiny over how they handled recalls linked to contaminated infant formula.
The contamination involved cereulide, a toxin that can cause vomiting and diarrhoea and is particularly risky for infants.
The affected ingredient was supplied by China's CABIO Biotech and was used by several infant formula makers, including Nestle, Danone and Lactalis.
The recall episode began in December 2025, when Nestle recalled dozens of infant formula batches in about 60 countries over possible cereulide contamination.
The recalls later widened to include Danone, Lactalis and smaller companies, continuing into February 2026.
A French parliamentary report published on May 19 said the handling of the case revealed shortcomings by both the French state and manufacturers.
The parliamentary review said limited resources for control authorities led to growing reliance on manufacturers' own checks, raising questions about oversight and crisis management.
Some aspects remain unresolved, including the full health impact of the contamination and the extent to which delays in alerts or recalls affected consumers.

How left and right are reading this

Both agree: A contamination scare involving infant formula exposed failures in oversight and recall handling, with a parliamentary review finding that under-resourced authorities relied too heavily on manufacturers’ own checks while key questions about health impact and delays remain unresolved.
They split on: Less a disagreement than a question of emphasis: the structural imbalance created when regulators depend on company self-checks, versus the broader breakdown of institutional and corporate responsibility once contamination spread across multiple manufacturers and countries.

Tuesday, May 19, 2026Science & ClimateWell-covered4 frames

Nestle and Danone are under renewed scrutiny over how they handled recalls linked to contaminated infant formula.
The contamination involved cereulide, a toxin that can cause vomiting and diarrhoea and is particularly risky for infants.
The affected ingredient was supplied by China's CABIO Biotech and was used by several infant formula makers, including Nestle, Danone and Lactalis.
The recall episode began in December 2025, when Nestle recalled dozens of infant formula batches in about 60 countries over possible cereulide contamination.
The recalls later widened to include Danone, Lactalis and smaller companies, continuing into February 2026.
A French parliamentary report published on May 19 said the handling of the case revealed shortcomings by both the French state and manufacturers.
The parliamentary review said limited resources for control authorities led to growing reliance on manufacturers' own checks, raising questions about oversight and crisis management.
Some aspects remain unresolved, including the full health impact of the contamination and the extent to which delays in alerts or recalls affected consumers.

How left and right are reading this

Both agree: A contamination scare involving infant formula exposed failures in oversight and recall handling, with a parliamentary review finding that under-resourced authorities relied too heavily on manufacturers’ own checks while key questions about health impact and delays remain unresolved.
They split on: Less a disagreement than a question of emphasis: the structural imbalance created when regulators depend on company self-checks, versus the broader breakdown of institutional and corporate responsibility once contamination spread across multiple manufacturers and countries.